Lincotek Group to expand medical division headquarters
September 20, 2024
Lincotek Group, headquartered in Rubbiano, Italy, has announced plans to expand its medical division’s headquarters in Trento, Italy. The new 4,000 m2 facility is expected to be operational in the second half of 2025, and will nearly double the company’s production footprint.
“We’re fully focused on the development of solutions for the orthopaedic sector at a time of increasing complexity and technological innovation,” said Andrea Colombo, Lincotek Group CEO. “The expansion of our facilities in Trento into a new hi-tech campus will help us meet the needs of customers into the future. It reflects our culture of continuous innovation and presents exciting new opportunities for everyone involved in our Medical Division.”
Fostering industry-academic collaboration, and leveraging the many years of experience and knowledge within the company, Lincotek envisions the campus as a hub for the cross-fertilisation of ideas. This is expected to strengthen its position as a centre of expertise with deep scientific and technological understanding. It will also allow the business to capitalise on trends towards automation, customisation and optimisation of the supply chain, while helping to reduce waste and contribute to a greener economy.
Gennaro D’Andrea, Global General Manager of the Medical Division, shared, “This is an exciting and inspiring time for the business, as we gear up to face the future and keep up with evolving customer expectations. With the investments we already approved and expect to be operative from the second half of 2025, we will increase our production capacity by 40%, ensuring new products get to market even quicker than they do today. We always invest to grow together with our customers – they can plan for the future with certainty, knowing we’ll be right at their side to support their projects and bolster their success.”
